Products
Profile
No detailed brain profile yet for Jonathan Rose. Directory data and live intelligence below.
Promos (0)
No analyzed promos yet.
Recent Emails
View all (23) in iSpy →- Read full email2026-10-29PROMOMasters in Trading: LiveTomorrow at 11: I’m Watching The Earnings Cycle’s Next WinnersJonathan Rose invites subscribers to a live video event (11 AM EST) analyzing AI earnings-cycle winners, with emphasis on memory-chip supply-chain bottlenecks and plays like Micron that can scale production. The email positions semiconductor supply as the primary constraint limiting the AI build-out and discusses cybersecurity and bond-market implications.
- Read full email2026-10-29PROMOMasters in Trading: LiveLIVE at 11: I Reviewed 36 Earnings Bets. Here Are the Names to Buy Before the Move.Jonathan Rose hosts a live Masters in Trading session analyzing 36 upcoming earnings reports through an options implied-move lens, focusing on stocks that consistently beat or miss volatility expectations. The email emphasizes a three-tier classification system and offers specific entry rules and position-sizing guidance for earnings trades.
- Read full email2026-10-28EDITORIALMasters in Trading: LiveWATCH NOW: One FDA Decision. 2 AI Biotech Stocks to Watch Before the Catalyst Hits.Jonathan Rose presents a video analysis of two AI-designed biotech stocks (Inovio and Precigen) correlated to an upcoming Friday FDA decision on a rare disease treatment. The email positions the FDA approval catalyst as a setup for contrasting stock movements and showcases Masters in Trading's event-driven trading methodology with institutional positioning context.
- Read full email2026-10-27PROMOMasters in Trading: LiveTomorrow at 11: The Next AI Trade Smart Money’s WatchingJonathan Rose is promoting tomorrow's Masters in Trading: Live event focusing on AI biotech stocks driven by FDA approval catalysts on the PDUFA calendar, specifically a Friday ruling on a rare airway disease treatment that will impact two opposing positions and a broader basket of biotech names. The email frames cybersecurity and biotech as overlooked AI infrastructure segments with predictable catalyst calendars.
- Read full email2026-10-27PROMOMasters in Trading: LiveLIVE at 11: Anthropic Just Committed $518B to AI. Here’s Who Gets Paid First.Masters in Trading: Live promotional email pitching a live video breakdown (11 AM EST) of Anthropic's confidential IPO filing, focusing on which suppliers will be paid regardless of revenue performance. The email emphasizes the 'picks and shovels' infrastructure play thesis where companies contracted to supply Anthropic get paid whether the AI boom continues or stumbles.
- Read full email2026-10-26PROMOMasters in Trading: LiveTomorrow at 11: Anthropic's IPO Has a $476 Billion SurpriseJonathan Rose (Masters in Trading: Live founder) promotes a live session analyzing Anthropic's IPO filing, which reveals $476 billion in computing commitments. The email frames cybersecurity and AI infrastructure plays as the real opportunities, positioning Anthropic as a case study in 'following the money' behind AI spending rather than investing directly in AI companies.
- Read full email2026-10-22PROMOMasters in Trading: LiveToday at 11: Is AI a Bubble? Here’s Where the Real Risk Is Building.InvestorPlace's Masters in Trading: Live promotes a live video discussion about AI bubble risks, arguing the real fragility lies in debt-financed AI buildout and interest-rate sensitivity rather than AI fundamentals. Jonathan Rose invites viewers to a paid $15 stock alert claiming orbital data centers and autonomous systems represent a $126 trillion opportunity.
- Read full email2026-10-21PROMOMasters in Trading: LiveTomorrow at 11: The AI Trade Has a Financing Problem. Here’s What Comes Next.Jonathan Rose (Masters in Trading: Live founder) promotes a live video event tomorrow at 11 AM featuring discussion with Louis Navellier, Eric Fry, Luke Lango, and Crystal about AI infrastructure financing fragility amid rising borrowing costs and potential Fed rate hikes. The email frames AI's biggest risk as capital structure (debt/circular financing) rather than technology itself, positioning the live event as urgent market insight before conditions shift.